List of works by Lisa H. Butterfield

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four -Fetoprotein Peptides

scientific article published on 01 May 2006

A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapies.

scientific article published on 5 November 2012

A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602)

scientific article

A short course of neoadjuvant IRX-2 induces changes in peripheral blood lymphocyte subsets of patients with head and neck squamous cell carcinoma

scientific article published on 23 November 2011

A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers".

scientific article

Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients.

scientific article

Antigen presentation by MART-1 adenovirus-transduced interleukin-10-polarized human monocyte-derived dendritic cells

scientific article published on 01 December 2004

Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem

scientific article

Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study.

scientific article published on 13 September 2016

Antioxidant function of recombinant human natural killer enhancing factor

scientific article

Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas

scientific article

B cells and tertiary lymphoid structures promote immunotherapy response

scientific article published on 15 January 2020

Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma

scientific article

Cancer immunotherapy trials: leading a paradigm shift in drug development

scientific article published on 19 July 2016

Cancer immunotherapy using gene-modified dendritic cells.

scientific article

Cancer vaccines

scientific article

Cellular immunity induced by a recombinant adenovirus- human dendritic cell vaccine for melanoma.

scientific article published on 18 November 2013

Cloning and analysis of MART-1/Melan-A human melanoma antigen promoter regions

scientific article published in June 1997

Cloning and sequence analysis of candidate human natural killer-enhancing factor genes

scientific article

Consensus nomenclature for CD8(+) T cell phenotypes in cancer

scientific article published on 25 February 2015

Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

scientific article published on 04 July 2019

Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee

scientific article published on 01 November 2020

Defining the critical hurdles in cancer immunotherapy

scientific article published on 14 December 2011

Dendritic Cell-Based Cancer Vaccines

scientific article

Dendritic cell control of immune responses

scientific article published on 5 February 2015

Dendritic cell-based vaccines positively impact natural killer and regulatory T cells in hepatocellular carcinoma patients.

scientific article

Dendritic cells in cancer immunotherapy clinical trials: are we making progress?

scientific article published on 13 December 2013

Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?

scientific article published on August 2011

Development of a potency assay for human dendritic cells: IL-12p70 production.

scientific article published on January 2008

Dysregulated NF-κB-Dependent ICOSL Expression in Human Dendritic Cell Vaccines Impairs T-cell Responses in Patients with Melanoma

scientific article published on 13 October 2020

Ectopic T-bet expression licenses dendritic cells for IL-12-independent priming of type 1 T cells in vitro.

scientific article

Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology

scientific article

Ependymomas: development of immunotherapeutic strategies.

scientific article published on October 2013

Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinoma

scientific article published on 18 February 2014

Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human alpha-fetoprotein

scientific article published in November 2000

From cytoprotection to tumor suppression: the multifactorial role of peroxiredoxins.

scientific article

Function but not phenotype of melanoma peptide-specific CD8(+) T cells correlate with survival in a multiepitope peptide vaccine trial (ECOG 1696).

scientific article

Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cells

scientific article published on January 2000

Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy

scientific article

Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab

scientific article published on 03 February 2014

Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomas

scientific article published on 15 March 2016

Immuno-oncology biomarkers 2010 and beyond: perspectives from the iSBTc/SITC biomarker task force.

scientific article

Immunogenicity and antitumor effects of vaccination with peptide vaccine+/-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696.

scientific article published on February 2009

Immunologic Monitoring of Cancer Vaccine Trials Using the ELISPOT Assay

scientific article published on 01 January 2014

Immunosuppressive effects of interleukin-12 coexpression in melanoma antigen gene-modified dendritic cell vaccines

scientific article

Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts

scientific article published on 15 January 2018

Immunotherapy biomarkers 2016: overcoming the barriers.

scientific article published on 21 March 2017

Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting.

scientific article published in December 2016

Immunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities

scientific article published on January 2012

Impact of checkpoint blockade on cancer vaccine-activated CD8+ T cell responses

scientific article published on 01 July 2020

Improving the therapeutic index in adoptive cell therapy: key factors that impact efficacy

scientific article published on 01 October 2020

Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulo

scientific article

Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC.

scientific article

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

scientific article published on 01 April 2020

Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial

scientific article

Lentivirally engineered dendritic cells activate AFP-specific T cells which inhibit hepatocellular carcinoma growth in vitro and in vivo.

scientific article

Lessons learned from cancer vaccine trials and target antigen choice

scientific article published on 03 February 2016

Measurements of natural killer (NK) cells.

scientific article

Melanoma antigen-specific effector T cell cytokine secretion patterns in patients treated with ipilimumab

scientific article

Melanoma cancer vaccines and anti-tumor T cell responses.

scientific article published on October 2007

Melanoma-associated leukoderma - immunology in black and white?

scientific article

Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanoma

scientific article published on 24 April 2019

Multiplex serum biomarker assessments: technical and biostatistical issues

scientific article published on 11 October 2011

Natural killer cells play a critical role in the immune response following immunization with melanoma-antigen-engineered dendritic cells

scientific article published in June 2005

Novel technologies and emerging biomarkers for personalized cancer immunotherapy

scientific article

Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge 2018" (28-29 November, 2018, Naples, Italy)

scientific article published on 29 November 2019

Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy).

scientific article published on 11 July 2018

Phase I dendritic cell p53 peptide vaccine for head and neck cancer

scientific article

Phenotypic and functional testing of circulating regulatory T cells in advanced melanoma patients treated with neoadjuvant ipilimumab.

scientific article published on 21 June 2016

Pitfalls in retrospective analyses of biomarkers: a case study with metastatic melanoma patients.

scientific article

Preamble to the 2015 SITC immunotherapy biomarkers taskforce

scientific article

Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma Patients

scientific article published on 20 July 2015

Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer.

scientific article published on 19 April 2016

Prospective Clinical Testing of Regulatory Dendritic Cells in Organ Transplantation

scientific article

Randomized controlled trial of a collaborative care intervention to manage cancer-related symptoms: lessons learned.

scientific article

Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After

scientific article

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers

scientific article

Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus

scientific article published on 17 May 2008

Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma

scientific article published on 21 July 2015

SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: online resources and useful tools - a compass in the land of biomarker discovery

scientific article

Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common rule

scientific article published on 21 June 2016

Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial

scientific article published on 03 June 2022

Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer.

scientific article published on 24 May 2007

Spontaneous immune responses against glioma-associated antigens in a long term survivor with malignant glioma.

scientific article

Surveillance of the eye and vision in a clinical trial of MART1-transformed dendritic cells for metastatic melanoma

scientific article

Systematic evaluation of immune regulation and modulation

scientific article published on 21 March 2017

The great debate at "Immunotherapy Bridge 2018", Naples, November 29th, 2018

scientific article published on 15 August 2019

The need for a network to establish and validate predictive biomarkers in cancer immunotherapy

scientific article published on 3 November 2017

Three antigen-loading methods in dendritic cell vaccines for metastatic melanoma.

scientific article published on 14 March 2018

Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

scientific article published on 22 May 2019

Tumor-Derived α-Fetoprotein Suppresses Fatty Acid Metabolism and Oxidative Phosphorylation in Dendritic Cells

scientific article published on 15 April 2019

Tumor-derived α-fetoprotein impairs the differentiation and T cell stimulatory activity of human dendritic cells

scientific article published on 29 October 2014

Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation

scientific article

Validation of biomarkers to predict response to immunotherapy in cancer: Volume II - clinical validation and regulatory considerations

scientific article

Web-based collaborative care intervention to manage cancer-related symptoms in the palliative care setting.

scientific article published on 11 March 2016

Zinc in innate and adaptive tumor immunity.

scientific article

α-Fetoprotein and other tumour-associated antigens for immunotherapy of hepatocellular cancer

scientific article published on 25 February 2008

Paulina is supported by:

About Paulina

Help